Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ipsen S.A. ADR (IPSEY)

Ipsen S.A. ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,329,361
  • Shares Outstanding, K 335,260
  • Annual Sales, $ 3,579 M
  • Annual Income, $ 697,430 K
  • 60-Month Beta 0.96
  • Price/Sales N/A
  • Price/Cash Flow 8.78
  • Price/Book N/A
Trade IPSEY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/08/24
  • Annual Dividend & Yield 0.21 (0.69%)
  • Most Recent Dividend 0.212 on 05/31/24
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.1600 +0.53%
on 06/27/24
33.9700 -10.74%
on 06/12/24
-3.1350 (-9.37%)
since 06/05/24
3-Month
28.6150 +5.96%
on 04/16/24
34.0600 -10.98%
on 05/24/24
+0.8700 (+2.95%)
since 04/05/24
52-Week
26.9700 +12.42%
on 12/04/23
34.3380 -11.70%
on 09/13/23
-0.3000 (-0.98%)
since 06/30/23

Most Recent Stories

More News
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvayâ„¢ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

/CNW/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

IPN : 34.71 (-0.54%)
IPSEY : 30.3200 (-1.59%)
Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U.

Regulatory News:

OTC.VN : 0.290 (-9.38%)
IPN : 34.71 (-0.54%)
IPSEY : 30.3200 (-1.59%)
Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI

Regulatory News:

OTC.VN : 0.290 (-9.38%)
IPN : 34.71 (-0.54%)
IPSEY : 30.3200 (-1.59%)
Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

AZN : 77.34 (+0.70%)
IPSEY : 30.3200 (-1.59%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Albireo Pharma, Inc....

IPSEY : 30.3200 (-1.59%)
ALBO : 44.15 (-0.23%)
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday

The market is moving higher, and these small companies are helping.

COMP : 3.60 (+2.56%)
$NASX : 18,352.76 (+0.90%)
DCT : 18.99 (unch)
ALBO : 44.15 (-0.23%)
IPSEY : 30.3200 (-1.59%)
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Regulatory News:

OTC.VN : 0.290 (-9.38%)
ALBO : 44.15 (-0.23%)
IPN : 34.71 (-0.54%)
IPSEY : 30.3200 (-1.59%)
Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva

Regulatory News:

OTC.VN : 0.290 (-9.38%)
IPN : 34.71 (-0.54%)
IPSEY : 30.3200 (-1.59%)
Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy

Regulatory News:

OTC.VN : 0.290 (-9.38%)
IPN : 34.71 (-0.54%)
IPSEY : 30.3200 (-1.59%)
Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Regulatory News:

OTC.VN : 0.290 (-9.38%)
IPN : 34.71 (-0.54%)
IPSEY : 30.3200 (-1.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.

See More

Key Turning Points

3rd Resistance Point 30.8100
2nd Resistance Point 30.8100
1st Resistance Point 30.8100
Last Price 30.3200
1st Support Level 30.8100
2nd Support Level 30.8100
3rd Support Level 30.8100

See More

52-Week High 34.3380
Fibonacci 61.8% 31.5234
Fibonacci 50% 30.6540
Last Price 30.3200
Fibonacci 38.2% 29.7846
52-Week Low 26.9700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar